Oxygen levels in prostate tumors may predict treatment success
NCT ID NCT00160979
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at oxygen levels inside prostate tumors in 186 men with early-stage prostate cancer. Researchers wanted to see if low oxygen (hypoxia) makes standard treatments like radiation less effective and increases the risk of cancer spreading. Participants had a special needle electrode placed through the rectum to measure oxygen before starting radiation or hormone therapy. The goal is to better understand why some prostate cancers come back and to guide future treatments that target low oxygen areas.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Princess Margaret Hospital
Toronto, Ontario, M5G 2M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug deliver a toxic payload to prostate cancer cells?
- Can AI outthink cancer experts? a landmark trial pits five AIs against tumor boards
- Hormone therapy showdown: can an oral pill beat the shot for prostate cancer patients?
- Can a new daily pill slow advanced prostate cancer?
- Immunotherapy combo takes on Hard-to-Treat prostate cancer
- Could a targeted drug delay prostate cancer progression?